Bortezomib-Induced Peripheral Neuropathy in Patients With Multiple Myeloma

被引:11
|
作者
Berkowitz, Anne [1 ]
Walker, Suzanne [2 ]
机构
[1] Univ Penn, Hematol Bone Marrow Transplant Dept, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Penn Presbyterian Med Ctr, Philadelphia, PA USA
关键词
MANAGEMENT; THERAPY;
D O I
10.1188/12.CJON.86-89
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bortezomib-induced peripheral neuropathy (BIPN) often is difficult to manage or reverse once it occurs. Treatment usually involves dose-reduction, interruption, or cessation of therapy, as no other interventions have been proven effective. Oncology nurses must be vigilant and recognize BIPN early to prevent patients from experiencing symptoms and complications that may interfere with their quality of life.
引用
收藏
页码:86 / 89
页数:4
相关论文
共 50 条
  • [1] BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY IN MULTIPLE MYELOMA PATIENTS
    Lalayanni, C.
    Iskas, M.
    Antoniou, A.
    Voutiadou, G.
    Georgiadou, E.
    Marvaki, A.
    Apostolou, C.
    Vadikoliou, C.
    Mallouri, D.
    Kaloyannidis, P.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2012, 97 : 615 - 616
  • [2] Bortezomib-induced peripheral neuropathy and neuronopathy in patients with multiple myeloma
    Turgut, N.
    Turgut, B.
    Oran, M.
    Yetisyigit, T.
    Alp, R.
    Unal, A.
    JOURNAL OF NEUROLOGY, 2013, 260 : S153 - S154
  • [3] Bortezomib-induced painful neuropathy in patients with multiple myeloma
    Bilinska, Malgorzata
    Usnarska-Zubkiewicz, Lidia
    Pokryszko-Dragan, Anna
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (05): : 421 - 426
  • [4] Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
    Argyriou, Andreas A.
    Iconomou, Gregoris
    Kalofonos, Haralabos P.
    BLOOD, 2008, 112 (05) : 1593 - 1599
  • [5] Impact of dose modification on intravenous Bortezomib-induced peripheral neuropathy in multiple myeloma patients
    Cho, Juhee
    Kang, Danbee
    Lee, Ji Yean
    Kim, Kihyun
    Kim, Seok Jin
    SUPPORTIVE CARE IN CANCER, 2014, 22 (10) : 2669 - 2675
  • [6] Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients
    Velasco, Roser
    Petit, Josep
    Clapes, Victoria
    Verdu, Enric
    Navarro, Xavier
    Bruna, Jordi
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2010, 15 (01) : 17 - 25
  • [7] A Pilot Study of Acupuncture in Treating Bortezomib-Induced Peripheral Neuropathy in Patients With Multiple Myeloma
    Bao, Ting
    Goloubeva, Olga
    Pelser, Colleen
    Porter, Neil
    Primrose, James
    Hester, Lisa
    Sadowska, Mariola
    Lapidus, Rena
    Medeiros, Michelle
    Lao, Lixing
    Dorsey, Susan G.
    Badros, Ashraf Z.
    INTEGRATIVE CANCER THERAPIES, 2014, 13 (05) : 396 - 404
  • [8] A PILOT STUDY OF ACUPUNCTURE IN TREATING BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY IN MULTIPLE MYELOMA PATIENTS
    Ting Bao
    Olga Goloubeva
    Colleen Pelser
    Neil Porter Porter
    James Primrose
    Lisa Hester Hester
    Mariola Sadowska
    Rena Lapidus
    Michelle Medeiros
    Lixing Lao
    Susan Dorsey
    Ashraf Badros
    Journal of Integrative Medicine, 2014, (03) : 301 - 301
  • [9] Impact of dose modification on intravenous Bortezomib-induced peripheral neuropathy in multiple myeloma patients
    Juhee Cho
    Danbee Kang
    Ji Yean Lee
    Kihyun Kim
    Seok Jin Kim
    Supportive Care in Cancer, 2014, 22 : 2669 - 2675
  • [10] A genetic variant study of bortezomib-induced peripheral neuropathy in Chinese multiple myeloma patients
    Zhang, Yan
    Zhang, Heyang
    Wang, Jing
    Wei, Xin
    Qu, Yi
    Xu, Feng
    Zhang, Lijun
    ONCOLOGY RESEARCH, 2024, 32 (05) : 955 - 963